PTGS2 and carcinoma: In this study, the serine protease inhibitor WK-UK1, the MMP inhibitor Galardin® and the selective COX-2 inhibitor Celecoxib® have been tested as a combinatorial treatment with chemical compounds against carcinoma cells.